| Typicality: | 0.360 |
| Saliency: | 0.258 |
| for first-line therapy | 6 | purpose |
| for intravenous administration | 5 | purpose |
| for someone with type 2 diabetes | 4 | other |
| insulin → be → appropriate | 11 |
| insulin → be → suitable | 5 |
| negative | neutral | positive |
| 0.214 | 0.540 | 0.246 |
| Raw frequency | 16 |
| Normalized frequency | 0.258 |
| Modifier score | 0.500 |
| Perplexity | 460.172 |